The programme of quality assurance of the EORTC radiotherapy group. A historical overview.

[1]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  J. Horiot,et al.  Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes , 1992 .

[3]  H. Bartelink,et al.  The conservative management of breast carcinoma by tumourectomy and radiotherapy: an EORTC phase III study (22881/10882) , 1991 .

[4]  A. Gerbaulet,et al.  Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  J. Horiot,et al.  Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Robert J. Shalek,et al.  Physical Aspects of Quality Assurance in Radiation Therapy , 1984 .

[7]  K. Ang,et al.  Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC. , 1982, International journal of radiation oncology, biology, physics.